Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Pension (2016 - 2019)

Harvard Bioscience (HBIO) has disclosed Pension for 9 consecutive years, with $900000.0 as the latest value for Q2 2019.

  • Quarterly Pension fell 25.0% to $900000.0 in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $900000.0 through Jun 2019, down 25.0% year-over-year, with the annual reading at $900000.0 for FY2018, 25.0% down from the prior year.
  • Pension for Q2 2019 was $900000.0 at Harvard Bioscience, roughly flat from $900000.0 in the prior quarter.
  • The five-year high for Pension was $4.6 million in Q2 2015, with the low at $900000.0 in Q4 2018.
  • Average Pension over 5 years is $2.6 million, with a median of $2.8 million recorded in 2015.
  • The sharpest move saw Pension soared 30.77% in 2017, then crashed 64.71% in 2018.
  • Over 5 years, Pension stood at $2.8 million in 2015, then rose by 7.14% to $3.0 million in 2016, then crashed by 60.0% to $1.2 million in 2017, then decreased by 25.0% to $900000.0 in 2018, then changed by 0.0% to $900000.0 in 2019.
  • According to Business Quant data, Pension over the past three periods came in at $900000.0, $900000.0, and $1.2 million for Q2 2019, Q4 2018, and Q3 2018 respectively.